Click here to get full coverage on Is It Time To Reassess Zai Lab (ZLAB) After Its Recent Share Price Swings? - simplywall.st

Is It Time To Reassess Zai Lab (ZLAB) After Its Recent Share Price Swings?  simplywall.st

Is It Time To Reassess Zai Lab (ZLAB) After Its Recent Share Price Swings? - simplywall.st

Click here to get full coverage on Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37 - Moomoo

Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37  Moomoo

Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37 - Moomoo

Click here to get full coverage on Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy - Yahoo Finance

Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy  Yahoo Finance

Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy - Yahoo Finance

Click here to get full coverage on Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases - Slideshow (NASDAQ:ZLAB) 2026-04-22 - Seeking Alpha

Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases - Slideshow (NASDAQ:ZLAB) 2026-04-22  Seeking Alpha

Zai Lab Limited (ZLAB) Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases - Slideshow (NASDAQ:ZLAB) 2026-04-22 - Seeking Alpha

Click here to get full coverage on Zai Lab (NASDAQ: ZLAB, HKEX: 9688) details 2026 AGM votes on board, pay, 10% mandates - Stock Titan

Zai Lab (NASDAQ: ZLAB, HKEX: 9688) details 2026 AGM votes on board, pay, 10% mandates  Stock Titan

Zai Lab (NASDAQ: ZLAB, HKEX: 9688) details 2026 AGM votes on board, pay, 10% mandates - Stock Titan

Click here to get full coverage on Micheal Alan Zlab Obituary December 18, 2025 - Legacy obituary

Micheal Alan Zlab Obituary December 18, 2025  Legacy obituary

Micheal Alan Zlab Obituary December 18, 2025 - Legacy obituary

Click here to get full coverage on The Technical Signals Behind (ZLAB) That Institutions Follow - Stock Traders Daily

The Technical Signals Behind (ZLAB) That Institutions Follow  Stock Traders Daily

The Technical Signals Behind (ZLAB) That Institutions Follow - Stock Traders Daily

Click here to get full coverage on Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages  MarketBeat

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Click here to get full coverage on Tanner Zlab - Football 2016 - University of Nebraska - Official Athletics Website - huskers.com

Tanner Zlab - Football 2016 - University of Nebraska - Official Athletics Website  huskers.com

Tanner Zlab - Football 2016 - University of Nebraska - Official Athletics Website - huskers.com

Click here to get full coverage on Zai Lab Limited - Depositary Receipt (ZLAB) price target increased by 19.30% to 26.69 - MSN

Zai Lab Limited - Depositary Receipt (ZLAB) price target increased by 19.30% to 26.69  MSN

Zai Lab Limited - Depositary Receipt (ZLAB) price target increased by 19.30% to 26.69 - MSN

Click here to get full coverage on Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After Recent Share Price Momentum Shift - Sahm

Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After Recent Share Price Momentum Shift  Sahm

Assessing Zai Lab (NasdaqGM:ZLAB) Valuation After Recent Share Price Momentum Shift - Sahm

Click here to get full coverage on Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target Reset - Yahoo Finance

Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target Reset  Yahoo Finance

Assessing Zai Lab (ZLAB) Valuation After Recent Share Price Momentum And Analyst Target Reset - Yahoo Finance

Click here to get full coverage on Is Zai Lab (ZLAB) Quietly Reframing Its Moat Around Differentiated DLL3 and Atopic Pipelines? - simplywall.st

Is Zai Lab (ZLAB) Quietly Reframing Its Moat Around Differentiated DLL3 and Atopic Pipelines?  simplywall.st

Is Zai Lab (ZLAB) Quietly Reframing Its Moat Around Differentiated DLL3 and Atopic Pipelines? - simplywall.st

Click here to get full coverage on Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative (NASDAQ:ZLAB) - Seeking Alpha

Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative (NASDAQ:ZLAB)  Seeking Alpha

Zai Lab: Xacduro And ZL-1310 Drive Growth Narrative (NASDAQ:ZLAB) - Seeking Alpha

Click here to get full coverage on Zai Lab (ZLAB) director adds 1,731 ADS in Rule 10b5-1 purchase - Stock Titan

Zai Lab (ZLAB) director adds 1,731 ADS in Rule 10b5-1 purchase  Stock Titan

Zai Lab (ZLAB) director adds 1,731 ADS in Rule 10b5-1 purchase - Stock Titan

Click here to get full coverage on Is Zai Lab (ZLAB) Now A Bargain After Recent 15.8% Share Price Jump? - Yahoo Finance

Is Zai Lab (ZLAB) Now A Bargain After Recent 15.8% Share Price Jump?  Yahoo Finance

Is Zai Lab (ZLAB) Now A Bargain After Recent 15.8% Share Price Jump? - Yahoo Finance

Click here to get full coverage on Is Zai Lab (ZLAB) Pricing Reflect Its Potential After Multi‑Year Share Price Slump - Yahoo Finance

Is Zai Lab (ZLAB) Pricing Reflect Its Potential After Multi‑Year Share Price Slump  Yahoo Finance

Is Zai Lab (ZLAB) Pricing Reflect Its Potential After Multi‑Year Share Price Slump - Yahoo Finance

Click here to get full coverage on UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform - Yahoo Finance

UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform  Yahoo Finance

UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform - Yahoo Finance

Click here to get full coverage on Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates  Yahoo Finance

Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Click here to get full coverage on Precision Trading with Zai Lab Limited (ZLAB) Risk Zones - Stock Traders Daily

Precision Trading with Zai Lab Limited (ZLAB) Risk Zones  Stock Traders Daily

Precision Trading with Zai Lab Limited (ZLAB) Risk Zones - Stock Traders Daily

Click here to get full coverage on Zai Lab (NASDAQ: ZLAB) reports 5.74M ADS (57.4M ordinary shares) - Stock Titan

Zai Lab (NASDAQ: ZLAB) reports 5.74M ADS (57.4M ordinary shares)  Stock Titan

Zai Lab (NASDAQ: ZLAB) reports 5.74M ADS (57.4M ordinary shares) - Stock Titan

Click here to get full coverage on Earnings Preview: Zai Lab to Report Financial Results Pre-market on May 07 - Moomoo

Earnings Preview: Zai Lab to Report Financial Results Pre-market on May 07  Moomoo

Earnings Preview: Zai Lab to Report Financial Results Pre-market on May 07 - Moomoo

Click here to get full coverage on JPMorgan Cuts PT on Zai Lab Limited (ZLAB) to $32 From $39 – Here’s Why - Yahoo Finance

JPMorgan Cuts PT on Zai Lab Limited (ZLAB) to $32 From $39 – Here’s Why  Yahoo Finance

JPMorgan Cuts PT on Zai Lab Limited (ZLAB) to $32 From $39 – Here’s Why - Yahoo Finance

Click here to get full coverage on Single dose cut itch for 112 days in Zai Lab atopic disease study - Stock Titan

Single dose cut itch for 112 days in Zai Lab atopic disease study  Stock Titan

Single dose cut itch for 112 days in Zai Lab atopic disease study - Stock Titan

Click here to get full coverage on ZLAB SEC Filings - Zai Lab Limited 10-K, 10-Q, 8-K Forms - Stock Titan

ZLAB SEC Filings - Zai Lab Limited 10-K, 10-Q, 8-K Forms  Stock Titan

ZLAB SEC Filings - Zai Lab Limited 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance

What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates  Yahoo Finance

What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance

Click here to get full coverage on Zai Lab gains after clinical trial pact with Amgen - Seeking Alpha

Zai Lab gains after clinical trial pact with Amgen  Seeking Alpha

Zai Lab gains after clinical trial pact with Amgen - Seeking Alpha

Click here to get full coverage on Zai Lab (ZLAB) officer auto-sells ADSs to cover RSU tax obligations - Stock Titan

Zai Lab (ZLAB) officer auto-sells ADSs to cover RSU tax obligations  Stock Titan

Zai Lab (ZLAB) officer auto-sells ADSs to cover RSU tax obligations - Stock Titan

Click here to get full coverage on A Look At Zai Lab (ZLAB) Valuation After A Sharp Pullback And Fair Value Gap - Yahoo Finance

A Look At Zai Lab (ZLAB) Valuation After A Sharp Pullback And Fair Value Gap  Yahoo Finance

A Look At Zai Lab (ZLAB) Valuation After A Sharp Pullback And Fair Value Gap - Yahoo Finance

Click here to get full coverage on Tax-driven Zai Lab (ZLAB) ADS sale reported for company executive - Stock Titan

Tax-driven Zai Lab (ZLAB) ADS sale reported for company executive  Stock Titan

Tax-driven Zai Lab (ZLAB) ADS sale reported for company executive - Stock Titan

Click here to get full coverage on Zai Lab (NASDAQ: ZLAB) CLO auto-sells 1,224 ADSs to cover RSU tax - Stock Titan

Zai Lab (NASDAQ: ZLAB) CLO auto-sells 1,224 ADSs to cover RSU tax  Stock Titan

Zai Lab (NASDAQ: ZLAB) CLO auto-sells 1,224 ADSs to cover RSU tax - Stock Titan

Click here to get full coverage on Zai Lab (ZLAB) CEO records small ADS sale to cover tax on RSUs - Stock Titan

Zai Lab (ZLAB) CEO records small ADS sale to cover tax on RSUs  Stock Titan

Zai Lab (ZLAB) CEO records small ADS sale to cover tax on RSUs - Stock Titan

Click here to get full coverage on ZLAB (NASDAQ: ZLAB) Form 144 shows Rafael Amado sold ADS in Mar–Apr 2026 - Stock Titan

ZLAB (NASDAQ: ZLAB) Form 144 shows Rafael Amado sold ADS in Mar–Apr 2026  Stock Titan

ZLAB (NASDAQ: ZLAB) Form 144 shows Rafael Amado sold ADS in Mar–Apr 2026 - Stock Titan

Click here to get full coverage on Zai Lab (NASDAQ: ZLAB) CFO sells 853 ADSs in tax-related RSU vesting - Stock Titan

Zai Lab (NASDAQ: ZLAB) CFO sells 853 ADSs in tax-related RSU vesting  Stock Titan

Zai Lab (NASDAQ: ZLAB) CFO sells 853 ADSs in tax-related RSU vesting - Stock Titan

Click here to get full coverage on Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st

Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know  simplywall.st

Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st

Click here to get full coverage on Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive - simplywall.st

Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive  simplywall.st

Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive - simplywall.st

Click here to get full coverage on ZLAB (NASDAQ: ZLAB) insider files Form 144 showing 11,580 ADS sales - Stock Titan

ZLAB (NASDAQ: ZLAB) insider files Form 144 showing 11,580 ADS sales  Stock Titan

ZLAB (NASDAQ: ZLAB) insider files Form 144 showing 11,580 ADS sales - Stock Titan

Click here to get full coverage on [144] Zai Lab Ltd SEC Filing - Stock Titan

[144] Zai Lab Ltd SEC Filing  Stock Titan

[144] Zai Lab Ltd SEC Filing - Stock Titan

Click here to get full coverage on Rafael Amado reports ADS sales for ZLAB (NASDAQ: ZLAB) - Stock Titan

Rafael Amado reports ADS sales for ZLAB (NASDAQ: ZLAB)  Stock Titan

Rafael Amado reports ADS sales for ZLAB (NASDAQ: ZLAB) - Stock Titan

Click here to get full coverage on Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy) - Seeking Alpha

Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy)  Seeking Alpha

Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy) - Seeking Alpha

Click here to get full coverage on Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance

Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges  Yahoo Finance

Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges - Yahoo Finance

Click here to get full coverage on Zai Lab (ZLAB) CEO nets shares after RSU vesting and tax sale - Stock Titan

Zai Lab (ZLAB) CEO nets shares after RSU vesting and tax sale  Stock Titan

Zai Lab (ZLAB) CEO nets shares after RSU vesting and tax sale - Stock Titan

Click here to get full coverage on Lung cancer drug from Zai Lab shows 68% tumor response in early data - Stock Titan

Lung cancer drug from Zai Lab shows 68% tumor response in early data  Stock Titan

Lung cancer drug from Zai Lab shows 68% tumor response in early data - Stock Titan

Click here to get full coverage on ZLAB (NASDAQ: ZLAB) notices proposed sale of 853 ADS; prior transfers listed - Stock Titan

ZLAB (NASDAQ: ZLAB) notices proposed sale of 853 ADS; prior transfers listed  Stock Titan

ZLAB (NASDAQ: ZLAB) notices proposed sale of 853 ADS; prior transfers listed - Stock Titan

Click here to get full coverage on 9,614 ADS tied to vesting listed by ZLAB (NASDAQ: ZLAB) with Fidelity broker - Stock Titan

9,614 ADS tied to vesting listed by ZLAB (NASDAQ: ZLAB) with Fidelity broker  Stock Titan

9,614 ADS tied to vesting listed by ZLAB (NASDAQ: ZLAB) with Fidelity broker - Stock Titan

Click here to get full coverage on Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - Business Wire

Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026  Business Wire

Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - Business Wire

Click here to get full coverage on Zai Lab Limited 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ZLAB) 2026-02-27 - Seeking Alpha

Zai Lab Limited 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ZLAB) 2026-02-27  Seeking Alpha

Zai Lab Limited 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ZLAB) 2026-02-27 - Seeking Alpha

Click here to get full coverage on New Analyst Forecast: $ZLAB Given $69.0 Price Target | ZLAB Stock News - Quiver Quantitative

New Analyst Forecast: $ZLAB Given $69.0 Price Target | ZLAB Stock News  Quiver Quantitative

New Analyst Forecast: $ZLAB Given $69.0 Price Target | ZLAB Stock News - Quiver Quantitative

Click here to get full coverage on Zai Lab (ZLAB) executive sells ADSs to cover tax after RSU vest - Stock Titan

Zai Lab (ZLAB) executive sells ADSs to cover tax after RSU vest  Stock Titan

Zai Lab (ZLAB) executive sells ADSs to cover tax after RSU vest - Stock Titan

Click here to get full coverage on Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st

Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB)  simplywall.st

Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st

Click here to get full coverage on Exploring the ZLab ZLand Mini – Unboxing & Details - Vaping360

Exploring the ZLab ZLand Mini – Unboxing & Details  Vaping360

Exploring the ZLab ZLand Mini – Unboxing & Details - Vaping360

Click here to get full coverage on Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛

Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37  富途牛牛

Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37 - 富途牛牛

Click here to get full coverage on Zai Lab AACR Update Puts Internal Oncology Pipeline And Global Aims In Focus - simplywall.st

Zai Lab AACR Update Puts Internal Oncology Pipeline And Global Aims In Focus  simplywall.st

Zai Lab AACR Update Puts Internal Oncology Pipeline And Global Aims In Focus - simplywall.st

Click here to get full coverage on Weekly Update: SLNO Acquisition, New Positions In GPCR, ZLAB (NASDAQ:GPCR) - Seeking Alpha

Weekly Update: SLNO Acquisition, New Positions In GPCR, ZLAB (NASDAQ:GPCR)  Seeking Alpha

Weekly Update: SLNO Acquisition, New Positions In GPCR, ZLAB (NASDAQ:GPCR) - Seeking Alpha

Click here to get full coverage on ZLAB (Zai Lab) beats Q4 2025 loss estimates, posts 15.3 percent year over year revenue gain, shares rise 3.93 percent. - Shared Momentum Picks - Cổng thông tin điện tử Tỉnh Sơn La

ZLAB (Zai Lab) beats Q4 2025 loss estimates, posts 15.3 percent year over year revenue gain, shares rise 3.93 percent. - Shared Momentum Picks  Cổng thông tin điện tử Tỉnh Sơn La

ZLAB (Zai Lab) beats Q4 2025 loss estimates, posts 15.3 percent year over year revenue gain, shares rise 3.93 percent. - Shared Momentum Picks - Cổng thông tin điện tử Tỉnh Sơn La

Click here to get full coverage on J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating - 富途牛牛

J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating  富途牛牛

J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating - 富途牛牛

Click here to get full coverage on ZLab ZLand: First Look & Unboxing - Vaping360

ZLab ZLand: First Look & Unboxing  Vaping360

ZLab ZLand: First Look & Unboxing - Vaping360

Click here to get full coverage on ZLAB (Zai Lab) Q4 2025 results outperform forecasts, shares rise 2.87 percent on 15.3 percent annual revenue growth. - Expert Momentum Signals - UBND thành phố Hải Phòng

ZLAB (Zai Lab) Q4 2025 results outperform forecasts, shares rise 2.87 percent on 15.3 percent annual revenue growth. - Expert Momentum Signals  UBND thành phố Hải Phòng

ZLAB (Zai Lab) Q4 2025 results outperform forecasts, shares rise 2.87 percent on 15.3 percent annual revenue growth. - Expert Momentum Signals - UBND thành phố Hải Phòng

Click here to get full coverage on Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena - DirectorsTalk Interviews

Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena  DirectorsTalk Interviews

Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena - DirectorsTalk Interviews

Click here to get full coverage on Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference  Business Wire

Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Click here to get full coverage on ZLAB (Zai Lab) Q4 2025 results outperform forecasts, shares rise 2.87 percent on 15.3 percent annual revenue growth. - Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh

ZLAB (Zai Lab) Q4 2025 results outperform forecasts, shares rise 2.87 percent on 15.3 percent annual revenue growth. - Stock Community Signals  Cổng thông tin điện tử tỉnh Tây Ninh

ZLAB (Zai Lab) Q4 2025 results outperform forecasts, shares rise 2.87 percent on 15.3 percent annual revenue growth. - Stock Community Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Click here to get full coverage on Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivo - Benzinga

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivo  Benzinga

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivo - Benzinga

Click here to get full coverage on ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView

ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks  TradingView

ETFs Investing in Zai Lab Ltd. Sponsored ADR Stocks - TradingView

Click here to get full coverage on Zai Lab Limited 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:ZLAB) 2025-11-12 - Seeking Alpha

Zai Lab Limited 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:ZLAB) 2025-11-12  Seeking Alpha

Zai Lab Limited 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:ZLAB) 2025-11-12 - Seeking Alpha

Click here to get full coverage on Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus

Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est  GuruFocus

Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus

Click here to get full coverage on ZLAB (Zai Lab) beats Q4 2025 loss estimates, posts 15.3 percent year over year revenue gain, shares rise 3.93 percent. - Expert Stock Picks - UBND thành phố Hải Phòng

ZLAB (Zai Lab) beats Q4 2025 loss estimates, posts 15.3 percent year over year revenue gain, shares rise 3.93 percent. - Expert Stock Picks  UBND thành phố Hải Phòng

ZLAB (Zai Lab) beats Q4 2025 loss estimates, posts 15.3 percent year over year revenue gain, shares rise 3.93 percent. - Expert Stock Picks - UBND thành phố Hải Phòng

Click here to get full coverage on Zai Lab: Global Pipeline Taking Shape, New Zoci Data Show Potential In A New Indication (NASDAQ:ZLAB) - Seeking Alpha

Zai Lab: Global Pipeline Taking Shape, New Zoci Data Show Potential In A New Indication (NASDAQ:ZLAB)  Seeking Alpha

ZLAB

Price Chart

Key Statistics

Technicals

About ZLAB

Latest News

Is It Time To Reassess Zai Lab (ZLAB) After Its Recent Share Price Swings? - simplywall.st

Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37 - Moomoo

Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers